Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other Accumulated Expenses: 2013-2025

Historic Other Accumulated Expenses for Fortress Biotech (FBIO) over the last 6 years, with Sep 2025 value amounting to $135,000.

  • Fortress Biotech's Other Accumulated Expenses fell 86.99% to $135,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $135,000, marking a year-over-year decrease of 86.99%. This contributed to the annual value of $1.5 million for FY2024, which is 822.70% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Other Accumulated Expenses is $135,000, which was down 93.48% from $2.1 million recorded in Q2 2025.
  • Fortress Biotech's Other Accumulated Expenses' 5-year high stood at $2.1 million during Q1 2025, with a 5-year trough of $135,000 in Q3 2025.
  • For the 3-year period, Fortress Biotech's Other Accumulated Expenses averaged around $929,273, with its median value being $1.0 million (2024).
  • Per our database at Business Quant, Fortress Biotech's Other Accumulated Expenses crashed by 87.97% in 2024 and then skyrocketed by 1,213.50% in 2025.
  • Over the past 4 years, Fortress Biotech's Other Accumulated Expenses (Quarterly) stood at $996,000 in 2022, then crashed by 83.63% to $163,000 in 2023, then spiked by 822.70% to $1.5 million in 2024, then plummeted by 86.99% to $135,000 in 2025.
  • Its Other Accumulated Expenses stands at $135,000 for Q3 2025, versus $2.1 million for Q2 2025 and $2.1 million for Q1 2025.